Spots Global Cancer Trial Database for Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma
Official Title: Aumolertinib as First-line Treatment in EGFR-Mutant Pulmonary Adenosquamous Carcinoma: A Multicenter, Single-Arm, Prospective Study (ARISE)
Study ID: NCT04354961
Conditions
Interventions
Study Description
Brief Summary: This is a prospective, multi-center, single-arm clinical trial.
Detailed Description: This is a multicenter, single arm, phase II study assessing the efficacy and safety of Almonertinib as first-line treatment in patients with EGFR mutation positive locally advanced or metastatic Pulmonary Adenosquamous Carcinoma.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Cancer Hospital, Beijing, , China
Beijing Chest Hospital, Capital Medical University, Beijing, , China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, , China
Hunan Cancer Hospital, Changsha, , China
The Second Xiangya Hospital of Central South University, Changsha, , China
Xinqiao Hospital, Army Medical University, Chongqing, , China
Fujian Cancer Hospital, Fuzhou, , China
Fujian Provincial Hospital, Fuzhou, , China
Sir Run Run Shaw Hospital, Hangzhou, , China
The second Affiliated Hospital of Kunming Medical University, Kunming, , China
The second Affiliated Hospital of Nanchang University, Nanchang, , China
Jiangsu Province Hospital, Nanjing, , China
Shanghai Chest Hospital, Shanghai, , China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, , China
Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology, Wuhan, , China
Air Force Medical University of PLA (the Fourth Military Medical University), Xi'an, , China
Henan Cancer Hospital, Zhengzhou, , China
Henan Provincial People's Hospital, Zhengzhou, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
